Vimarsana
Biggest News Aggregation in the World

Advent Funds News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Advent Funds. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Advent Funds Today - Breaking & Trending Today

Zentiva S A : SCD_Zentiva_Annual Report 2023-EN - Vimarsana News

Zentiva S A : SCD_Zentiva_Annual Report 2023-EN

Annual Report of the Board of Directors for the financial year 2023 Reporting date: 31 December 2023 ...

PE firm Advent acquires 50.1% stake in Suven Pharma at Rs 495/share, to make open offer for additional 26% stake - Vimarsana News

PE firm Advent acquires 50.1% stake in Suven Pharma at Rs 495/share, to make open offer for additional 26% stake

Advent also announced the new Board of Directors and management team for Suven Pharma, including Sudhir Kumar Singh as CEO

Suven Pharma soars 6% as cabinet committee greenlights Rs 9,589 crore FDI deal - Vimarsana News

Suven Pharma soars 6% as cabinet committee greenlights Rs 9,589 crore FDI deal

The approval is for the acquisition of up to 76.1 percent stake in Suven Pharmaceuticals by Cyprus-based Berhyanda Ltd.

Suven Pharmaceuticals | Government approves FDI of up to Rs 9,589 crore in Suven Pharmaceuticals by Cyprus-based Berhyanda Ltd - Vimarsana News

Suven Pharmaceuticals | Government approves FDI of up to Rs 9,589 crore in Suven Pharmaceuticals by Cyprus-based Berhyanda Ltd

Proposal has been evaluated by Sebi, RBI, CCI and other relevant agencies, after meeting of Cabinet Committee on Economic Affairs

Suven Pharma: Cabinet clears Advent's acquisition of Suven Pharma for Rs 9,589 crore - Vimarsana News

Suven Pharma: Cabinet clears Advent's acquisition of Suven Pharma for Rs 9,589 crore

The Indian government has approved a foreign direct investment (FDI) proposal worth Rs. 9,589 crore in Suven Pharmaceuticals Limited. Private equity firm Advent International will acquire a 50.1% stake in the company for Rs. 6,313 crore, with plans to launch an open offer for an additional 26%.